Thermo Fisher Scientific logo

Thermo Fisher Scientific (TMO) Q1 2026 Earnings

TMO·Reported April 23, 2026·Before market open

Thermo Fisher Scientific reported Q1 2026 revenue of $11.0B (+6.2% YoY), beat analyst consensus of $10.9B by $140.3M. Diluted EPS came in at $5.44 (+5.6% YoY), beat the $5.25 consensus by $0.19. Thermo Fisher Scientific reports across 4 business segments, led by Life Sciences Solutions, Laboratory Products and Biopharma Services, and Analytical Instruments.

Revenue
$11.0Bbeat by $140.3M
Consensus: $10.9B
Diluted EPS
$5.44beat by $0.19
Consensus: $5.25
SEC

SEC Filings

Earnings release8-K · 0000097745-26-000086
Quarterly report10-Q · 0000097745-26-000092

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Net Income

View metric

Q1 2026 Earnings FAQ

Common questions about Thermo Fisher Scientific's Q1 2026 earnings report.

Thermo Fisher Scientific (TMO) reported Q1 2026 earnings on April 23, 2026 before market open.

Thermo Fisher Scientific reported revenue of $11.0B and diluted EPS of $5.44 for Q1 2026.

Revenue beat the consensus estimate of $10.9B by $140.3M. EPS beat the consensus estimate of $5.25 by $0.19.

Compared to the same quarter a year prior, revenue grew 6.2% from $10.4B a year earlier and diluted EPS grew 5.6% from $5.15.

You can read the 8-K earnings release (0000097745-26-000086) and the 10-Q periodic report (0000097745-26-000092) directly on SEC EDGAR. The filing index links above go to sec.gov.